YouTube Facebook LinkedIn Google+ Twitter Xingrss  

Adaptive Trials Growing Among CROs, Pharma



June 5, 2013 | Adaptive trials continue to gain ground, says Ken Getz, Director of the Tufts Center for the Study of Drug Development. He says the industry as a whole is seeing an adoption rate of about 20%, with regulators receptive to even broader implementation. Outsourcing Pharma
Click here to log in.

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1


For reprints and/or copyright permission, please contact  Terry Manning, 781.972.1349 , tmanning@healthtech.com.